Prothena Corporation plc
Prothena Corporation plc (PRTA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PRTA · as of Jun 9, 2026
Key Statistics
Explore Prothena Corporation plc Data
prta stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 28 · Buy rate: 71.4%
The PRTA analyst consensus is Buy, based on ratings from 28 Wall Street analysts over the past 3 months. The average 12-month price target is $19.00, representing +121.96% upside from the current price of $8.56.
Competitors & Peers
prta competitorsPRTA
BCYC
CRVS
FDMT
GOSS
KALVStock Performance
Full HistoryAbout Prothena Corporation plc
Prothena Corporation plc Established in 2012 and headquartered in Dublin, Ireland, Prothena Corporation plc functions as a clinical-stage biopharmaceutical company focused on the discovery and advancement of novel therapeutic…
what is prothena corporation plc · prta stock overview · prothena corporation plc company profile · who is prothena corporation plc ceo · prta NASDAQ · prothena corporation plc headquarters · prothena corporation plc business segments
About Stock Overview & Key Data
Prothena Corporation plc (PRTA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 18, 2012. As of the latest trading session, PRTA stock price is $8.56, with a market capitalization of $448.1M. The stock has returned +63.05% over the past 12 months and -10.37% year-to-date.
According to 28 Wall Street analysts, the consensus rating for Prothena Corporation plc stock is Buy, with an average 12-month price target of $19.00. In fiscal year 2025, Prothena Corporation plc reported revenue of $9.7M and net income of -$244.1M. For detailed data — including Prothena Corporation plc revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Prothena Corporation plc (PRTA) stock price is $8.56. The stock is traded on NASDAQ under the ticker symbol PRTA. The 52-week range is $4.95 – $11.80.